2023 Q3 Form 10-Q Financial Statement

#000147793223006216 Filed on August 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q1 2022 Q3
Revenue $4.000M $2.979M $3.525M
YoY Change 13.48% 61.27% 47.94%
Cost Of Revenue $3.020M $2.220M $2.490M
YoY Change 21.26% 71.57% 62.78%
Gross Profit $980.0K $758.7K $1.034M
YoY Change -5.26% 37.18% 21.31%
Gross Profit Margin 24.5% 25.47% 29.35%
Selling, General & Admin $670.0K $942.1K $716.9K
YoY Change -6.55% 156.88% 153.56%
% of Gross Profit 68.37% 124.18% 69.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $192.5K $142.5K $109.3K
YoY Change 76.17% 136.53% 84.84%
% of Gross Profit 19.64% 18.78% 10.56%
Operating Expenses $1.060M $1.244M $1.039M
YoY Change 2.07% 129.54% 120.88%
Operating Profit -$79.55K -$484.9K -$4.148K
YoY Change 1817.74% -4391.42% -101.07%
Interest Expense $24.38K $52.82K $26.19K
YoY Change -6.93% -551.07% -70.79%
% of Operating Profit
Other Income/Expense, Net $0.00 -$80.65K
YoY Change
Pretax Income -$285.7K -$512.8K -$115.3K
YoY Change 147.87% 121983.33% -138.75%
Income Tax -$52.00K -$175.0K -$23.00K
% Of Pretax Income
Net Earnings -$233.7K -$337.8K -$92.28K
YoY Change 153.3% -1474.08% -143.42%
Net Earnings / Revenue -5.84% -11.34% -2.62%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.04 -$0.05 -$14.28K
COMMON SHARES
Basic Shares Outstanding 6.246M shares 6.461M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q1 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.099M $8.145M $8.824M
YoY Change -19.54% -34.24% 412.73%
Cash & Equivalents $5.705M $2.151M $8.296M
Short-Term Investments $1.395M $5.994M $527.8K
Other Short-Term Assets $320.0K $483.9K $53.46K
YoY Change 498.58% 1679.77% 161.67%
Inventory $191.2K $158.4K $146.9K
Prepaid Expenses
Receivables $40.00K $76.95K $36.07K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.482M $8.864M $9.060M
YoY Change -17.42% -29.45% 391.44%
LONG-TERM ASSETS
Property, Plant & Equipment $3.277M $3.295M $2.962M
YoY Change 10.63% 106.91% 86.61%
Goodwill $671.2K $671.2K $488.4K
YoY Change 37.42%
Intangibles $411.7K $454.0K $425.0K
YoY Change -3.13%
Long-Term Investments $1.220M $1.369M $1.550M
YoY Change -21.28% 1725.59% 1966.44%
Other Assets $190.0K $111.9K $285.3K
YoY Change -33.4% -59.13% 3.98%
Total Long-Term Assets $7.668M $7.906M $6.872M
YoY Change 11.58% 307.26% 254.85%
TOTAL ASSETS
Total Short-Term Assets $7.482M $8.864M $9.060M
Total Long-Term Assets $7.668M $7.906M $6.872M
Total Assets $15.15M $16.77M $15.93M
YoY Change -4.91% 15.61% 321.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $639.2K $448.6K $498.3K
YoY Change 28.29% 53.65% 25.1%
Accrued Expenses $451.9K $532.5K $575.8K
YoY Change -21.52% 109.37% 121.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $791.4K $0.00
YoY Change
Long-Term Debt Due $164.9K $167.6K $171.4K
YoY Change -3.79% -1.35% -1.72%
Total Short-Term Liabilities $1.542M $2.134M $1.388M
YoY Change 11.13% 130.58% 46.79%
LONG-TERM LIABILITIES
Long-Term Debt $2.375M $2.658M $2.750M
YoY Change -13.66% -6.16% -9.64%
Other Long-Term Liabilities $1.630M $1.825M $1.016M
YoY Change 60.49% -6083633.33%
Total Long-Term Liabilities $2.375M $2.658M $2.750M
YoY Change -13.66% -6.16% -9.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.542M $2.134M $1.388M
Total Long-Term Liabilities $2.375M $2.658M $2.750M
Total Liabilities $5.546M $6.617M $5.205M
YoY Change 6.54% 70.66% 25.88%
SHAREHOLDERS EQUITY
Retained Earnings -$1.538M -$1.163M -$649.9K
YoY Change 136.67% 93.68% -24.49%
Common Stock $12.49K $12.79K $12.92K
YoY Change -3.33% -0.8% 59.63%
Preferred Stock
YoY Change
Treasury Stock (at cost) $356.8K $106.9K
YoY Change
Treasury Stock Shares
Shareholders Equity $9.604M $10.15M $10.73M
YoY Change
Total Liabilities & Shareholders Equity $15.15M $16.77M $15.93M
YoY Change -4.91% 15.61% 321.46%

Cashflow Statement

Concept 2023 Q3 2023 Q1 2022 Q3
OPERATING ACTIVITIES
Net Income -$233.7K -$337.8K -$92.28K
YoY Change 153.3% -1474.08% -143.42%
Depreciation, Depletion And Amortization $192.5K $142.5K $109.3K
YoY Change 76.17% 136.53% 84.84%
Cash From Operating Activities $360.0K -$272.7K $160.7K
YoY Change 124.05% 132.34% -36.73%
INVESTING ACTIVITIES
Capital Expenditures $160.0K $128.7K -$1.309M
YoY Change -112.22% -205.37% 4878.81%
Acquisitions
YoY Change
Other Investing Activities $50.00K -$5.255M -$1.588M
YoY Change -103.15%
Cash From Investing Activities -$100.0K -$5.384M -$2.897M
YoY Change -96.55% 4309.49% 10917.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K 641.6K -41.80K
YoY Change -4.31% -93.92% -226.09%
NET CHANGE
Cash From Operating Activities 360.0K -272.7K 160.7K
Cash From Investing Activities -100.0K -5.384M -2.897M
Cash From Financing Activities -40.00K 641.6K -41.80K
Net Change In Cash 220.0K -5.015M -2.778M
YoY Change -107.92% -148.66% -1164.98%
FREE CASH FLOW
Cash From Operating Activities $360.0K -$272.7K $160.7K
Capital Expenditures $160.0K $128.7K -$1.309M
Free Cash Flow $200.0K -$401.4K $1.470M
YoY Change -86.39% -8585.41% 424.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001718224
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-01
dei Entity Shell Company
EntityShellCompany
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6246118 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6396118 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.00
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-07-02
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-233233
dei Entity Registrant Name
EntityRegistrantName
BT BRANDS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-1495764
dei Entity Address Address Line1
EntityAddressAddressLine1
405 Main Avenue West
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 2D
dei Entity Address City Or Town
EntityAddressCityOrTown
West Fargo
dei Entity Address State Or Province
EntityAddressStateOrProvince
ND
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
58078
dei City Area Code
CityAreaCode
307
dei Local Phone Number
LocalPhoneNumber
274-3055
dei Security12b Title
Security12bTitle
Common stock, $0.002 per share
dei Trading Symbol
TradingSymbol
BTBD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6246118 shares
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5704879 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2023Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1233796 usd
CY2023Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
5994295 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
35412 usd
CY2023Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
76948 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
191206 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
158351 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
58140 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37397 usd
CY2023Q3 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
258751 usd
CY2023Q1 us-gaap Assets Held For Sale Not Part Of Disposal Group Current
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
446524 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
7482184 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
8864093 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3276683 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3294644 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1890044 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2004673 usd
CY2023Q3 us-gaap Investments
Investments
1224837 usd
CY2023Q1 us-gaap Investments
Investments
1369186 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
143000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
61000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
671220 usd
CY2023Q1 us-gaap Goodwill
Goodwill
671220 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
411713 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
453978 usd
CY2023Q3 us-gaap Other Assets
OtherAssets
50052 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
50903 usd
CY2023Q3 us-gaap Assets
Assets
15149733 usd
CY2023Q1 us-gaap Assets
Assets
16769697 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
639226 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
448605 usd
CY2023Q3 btbd Broker Margin Loan Current
BrokerMarginLoanCurrent
0 usd
CY2023Q1 btbd Broker Margin Loan Current
BrokerMarginLoanCurrent
791370 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
164866 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
167616 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
286114 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
193430 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
451891 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
532520 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1542097 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2133541 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2374705 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2658477 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1628754 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1825057 usd
CY2023Q3 us-gaap Liabilities
Liabilities
5545556 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6617075 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.002
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6246118 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6396118 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
12492 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
12792 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
215000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
65000 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
356807 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
106882 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11486535 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11409235 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1538043 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1162523 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
9604177 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10152622 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15149733 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
16769697 usd
us-gaap Revenues
Revenues
7070763 usd
us-gaap Revenues
Revenues
5598076 usd
CY2023Q3 us-gaap Revenues
Revenues
3999965 usd
CY2022Q3 us-gaap Revenues
Revenues
3524881 usd
btbd Food And Paper Costs Expenses
FoodAndPaperCostsExpenses
2898498 usd
btbd Food And Paper Costs Expenses
FoodAndPaperCostsExpenses
2032956 usd
CY2023Q3 btbd Food And Paper Costs Expenses
FoodAndPaperCostsExpenses
1608175 usd
CY2022Q3 btbd Food And Paper Costs Expenses
FoodAndPaperCostsExpenses
1311373 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
2615136 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
1786828 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1412376 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1179118 usd
us-gaap Occupancy Net
OccupancyNet
505861 usd
us-gaap Occupancy Net
OccupancyNet
435920 usd
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
148736 usd
CY2022Q3 us-gaap Occupancy Net
OccupancyNet
261282 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
394243 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
332181 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
198629 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
212314 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
356027 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
178701 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
192520 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
109286 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
944992 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
746717 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
519077 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
455656 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
313688 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2023Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
CY2022Q3 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Costs And Expenses
CostsAndExpenses
7401069 usd
us-gaap Costs And Expenses
CostsAndExpenses
5513303 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
4079513 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
3529029 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-330306 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
84773 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-79548 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4148 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-23064 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-80238 usd
CY2023Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-92919 usd
CY2022Q3 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-80238 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
90810 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
9473 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
1761 usd
CY2022Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
9473 usd
us-gaap Interest Expense
InterestExpense
49909 usd
us-gaap Interest Expense
InterestExpense
54461 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
24376 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
26190 usd
btbd Income Loss From Equity Method Investments Affiliate
IncomeLossFromEquityMethodInvestmentsAffiliate
-145050 usd
btbd Income Loss From Equity Method Investments Affiliate
IncomeLossFromEquityMethodInvestmentsAffiliate
-14172 usd
CY2023Q3 btbd Income Loss From Equity Method Investments Affiliate
IncomeLossFromEquityMethodInvestmentsAffiliate
-90651 usd
CY2022Q3 btbd Income Loss From Equity Method Investments Affiliate
IncomeLossFromEquityMethodInvestmentsAffiliate
-14172 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-457520 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54625 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-285734 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-115275 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-82000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-52000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-23000 usd
us-gaap Net Income Loss
NetIncomeLoss
-375520 usd
us-gaap Net Income Loss
NetIncomeLoss
-49625 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-233734 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-92275 usd
btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.06
btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
CY2023Q3 btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.04
CY2022Q3 btbd Net Loss Per Common Share Basic And Diluted
NetLossPerCommonShareBasicAndDiluted
-0.01
btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6261631 shares
btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6458276 shares
CY2023Q3 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6246114 shares
CY2022Q3 btbd Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
6461118 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
10152622 usd
btbd Stock Based Compensation
StockBasedCompensation
77300 usd
btbd Treasury Stock Purchase Amount
TreasuryStockPurchaseAmount
-250225 usd
us-gaap Net Income Loss
NetIncomeLoss
-375520 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
9604177 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
10628353 usd
btbd Stock Based Compensation
StockBasedCompensation
73400 usd
btbd Shares Issued In Exercise Of Warrants Amount
SharesIssuedInExerciseOfWarrantsAmount
74866 usd
us-gaap Net Income Loss
NetIncomeLoss
-49625 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
10726994 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
9796511 usd
CY2023Q3 btbd Stock Based Compensation
StockBasedCompensation
41400 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-233734 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
9604177 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10779369 usd
CY2022Q3 btbd Stock Based Compensation
StockBasedCompensation
39900 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-92275 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
10726994 usd
us-gaap Net Income Loss
NetIncomeLoss
-375520 usd
us-gaap Net Income Loss
NetIncomeLoss
-49625 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
356027 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
178701 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2700 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2700 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-82000 usd
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-67490 usd
btbd Share Based Compensations
ShareBasedCompensations
77300 usd
btbd Share Based Compensations
ShareBasedCompensations
73400 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-23064 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-80238 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
29178 usd
us-gaap Gain On Sale Of Investments
GainOnSaleOfInvestments
0 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
145050 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
14172 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
313688 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
10309 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
0 usd
us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
181339 usd
us-gaap Product Liability Accrual Period Expense
ProductLiabilityAccrualPeriodExpense
0 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
41536 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
36183 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-32855 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33833 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20743 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26274 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
166879 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
206284 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
100710 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
284700 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-201088 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-111747 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
498068 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-1150000 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1159600 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
1260000 usd
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
496000 usd
us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
265747 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
159491 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
0 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
229000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1091736 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
607988 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5858348 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
0 usd
us-gaap Other Payments To Acquire Businesses
OtherPaymentsToAcquireBusinesses
12500 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
4996865 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4578579 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
791370 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
289222 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
84035 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
74866 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
250225 usd
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1330817 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9169 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3554301 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4089680 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2150578 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12385632 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5704879 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8295952 usd
us-gaap Interest Paid Net
InterestPaidNet
47209 usd
us-gaap Interest Paid Net
InterestPaidNet
51761 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
209088 usd
btbd Purchase Of Property And Equipment Included In Accounts Payable Non Cash
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableNonCash
23742 usd
btbd Purchase Of Property And Equipment Included In Accounts Payable Non Cash
PurchaseOfPropertyAndEquipmentIncludedInAccountsPayableNonCash
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and the differences could be material.</p>
us-gaap Fiscal Period
FiscalPeriod
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Our fiscal year is a 52/53-week year, ending on Sunday, closest to December 31. Most years consist of four 13-week accounting periods comprising the 52-week year. All references to years in this report refer to the 13-week periods in the respective fiscal year periods. The fiscal year 2023 is 52 weeks ending December 31, 2023.</p>
CY2023Q3 btbd Cost Of Marketable Securities Bond Fund
CostOfMarketableSecuritiesBondFund
416570 usd
CY2023Q3 btbd Costs Of Marketable Securities Common Stock
CostsOfMarketableSecuritiesCommonStock
978040 usd
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
1394610 usd
CY2023Q3 us-gaap Market Risk Benefit After Increase Decrease From Instrument Specific Credit Risk
MarketRiskBenefitAfterIncreaseDecreaseFromInstrumentSpecificCreditRisk
160814 usd
CY2023Q1 us-gaap Common Stock Issued Employee Trust Deferred
CommonStockIssuedEmployeeTrustDeferred
713900 usd
CY2023Q1 us-gaap Cash Segregated Under Commodity Exchange Act Regulation
CashSegregatedUnderCommodityExchangeActRegulation
316000 usd
CY2023Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
1029900 usd
CY2023Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
1233796 usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
313688 usd
btbd Gain Loss On Sale Of Accrued Property Taxes
GainLossOnSaleOfAccruedPropertyTaxes
180000 usd
btbd Business Acquisition Percentage Of Voting Interests Granted As Consideration To Related Party
BusinessAcquisitionPercentageOfVotingInterestsGrantedAsConsiderationToRelatedParty
0.275 pure
btbd Finite Lived Intangible Assets Remaining Amortization Periods1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriods1
P14Y
btbd Finite Lived Intangible Asset Useful Lifes
FiniteLivedIntangibleAssetUsefulLifes
P15Y
CY2022 us-gaap Exploration Expense
ExplorationExpense
26000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
192520 usd
CY2022Q3 us-gaap Depreciation
Depreciation
109286 usd
btbd Share Based Payment Award Fair Value Compensation Expense
ShareBasedPaymentAwardFairValueCompensationExpense
250000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y1M6D
us-gaap Share Based Compensation
ShareBasedCompensation
41300 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.044 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.63 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
220250 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.74
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y6M
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
94950 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.18
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y6M
CY2023Q1 btbd Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Grant In Period
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateGrantInPeriod
250000 shares
CY2023Q1 us-gaap Share Price
SharePrice
8.50
CY2023Q1 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 integer
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.00
btbd Incremental Borrowing Rate
IncrementalBorrowingRate
0.045 pure
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
141576 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
289076 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
297745 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
306674 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
268437 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1039438 usd
CY2023Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2342966 usd
CY2023Q3 btbd Operating Leases Future Minimum Interest
OperatingLeasesFutureMinimumInterest
-428098 usd
CY2023Q3 btbd Present Value Of Lease Payments
PresentValueOfLeasePayments
1914868 usd
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y7M6D
us-gaap Operating Lease Payments
OperatingLeasePayments
223589 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
97887 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
141426 usd
us-gaap Variable Lease Cost
VariableLeaseCost
28500 usd

Files In Submission

Name View Source Status
0001477932-23-006216-index-headers.html Edgar Link pending
0001477932-23-006216-index.html Edgar Link pending
0001477932-23-006216.txt Edgar Link pending
0001477932-23-006216-xbrl.zip Edgar Link pending
btbd-20230702.xsd Edgar Link pending
btbd_10q.htm Edgar Link pending
btbd_10qimg1.jpg Edgar Link pending
btbd_ex311.htm Edgar Link pending
btbd_ex312.htm Edgar Link pending
btbd_ex321.htm Edgar Link pending
btbd_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
btbd-20230702_pre.xml Edgar Link unprocessable
btbd-20230702_cal.xml Edgar Link unprocessable
btbd-20230702_def.xml Edgar Link unprocessable
btbd-20230702_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
btbd_10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending